OTC: NWHUF - NorthWest Healthcare Properties Real Estate Investment Trust

Yield per half year: -2.82%
Sector: Real Estate

Company Analysis NorthWest Healthcare Properties Real Estate Investment Trust

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (3.44 $) is less than fair price (3.9 $)
  • Dividends (12.59%) are higher than the sector average (9.49%).
  • The stock's return over the last year (7.17%) is higher than the sector average (-30.25%).
  • Current debt level 51.1% is below 100% and has decreased over 5 years from 54.71%.

Disadvantages

  • The company's current efficiency (ROE=-13.16%) is lower than the sector average (ROE=1.17%)

Similar companies

Inmobiliaria Colonial, SOCIMI, S.A.

Ascendas Real Estate Investment Trust

Daiwa House Industry Co.,Ltd.

Fibra UNO

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

NorthWest Healthcare Properties Real Estate Investment Trust Real Estate Index
7 days -12.7% 0.4% 0.6%
90 days -4.4% -39.9% 9.2%
1 year 7.2% -30.2% 33.2%

NWHUF vs Sector: NorthWest Healthcare Properties Real Estate Investment Trust has outperformed the "Real Estate" sector by 37.41% over the past year.

NWHUF vs Market: NorthWest Healthcare Properties Real Estate Investment Trust has significantly underperformed the market by -26.01% over the past year.

Stable price: NWHUF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.

Long period: NWHUF with weekly volatility of 0.1378% over the past year.

3. Summary of the report

3.1. General

P/E: 18.4
P/S: 2.42

3.2. Revenue

EPS -1.06
ROE -13.16%
ROA -3.44%
ROIC 0%
Ebitda margin 75.56%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (3.44 $) is lower than the fair price (3.9 $).

Price not significantly lower than the fair price: The current price (3.44 $) is slightly lower than the fair price by 13.4%.

4.2. P/E

P/E vs Sector: The company's P/E (18.4) is lower than that of the sector as a whole (25.76).

P/E vs Market: The company's P/E (18.4) is lower than that of the market as a whole (53.07).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (0.3004) is lower than that of the sector as a whole (0.6983).

P/BV vs Market: The company's P/BV (0.3004) is higher than that of the market as a whole (-9.1).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (2.42) is lower than that of the sector as a whole (4.04).

P/S vs Market: The company's P/S indicator (2.42) is lower than that of the market as a whole (5.18).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (16.47) is lower than that of the sector as a whole (110.88).

EV/Ebitda vs Market: The company's EV/Ebitda (16.47) is lower than that of the market as a whole (23.95).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -93.58% over the last 5 years.

Accelerating profitability: The return for the last year (2.38%) exceeds the average return for 5 years (-93.58%).

Profitability vs Sector: The return for the last year (2.38%) is lower than the return for the sector (39.28%).

5.4. ROE

ROE vs Sector: The company's ROE (-13.16%) is lower than that of the sector as a whole (1.17%).

ROE vs Market: The company's ROE (-13.16%) is lower than that of the market as a whole (-2.01%).

5.5. ROA

ROA vs Sector: The company's ROA (-3.44%) is lower than that of the sector as a whole (9.64%).

ROA vs Market: The company's ROA (-3.44%) is lower than that of the market as a whole (8.98%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (4.91%).

ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.03%).

6. Finance

6.1. Assets and debt

Debt level: (51.1%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 54.71% to 51.1%.

Excess of debt: The debt is not covered by net income, percentage -1486.08%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

High yield: The dividend yield of the company 12.59% is higher than the average for the sector '9.49%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 12.59% has been steadily paid over the past 7 years, DSI=0.79.

Weak dividend growth: The company's dividend yield 12.59% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (124.27%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

No insider transactions have been recorded yet

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum NorthWest Healthcare Properties Real Estate Investment Trust

9.3. Comments